Balyasny Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
110,491
-37,649
| -25% | -$142K | ﹤0.01% | 1615 |
|
|
2025
Q1 | $671K | Buy |
+148,140
| New | +$671K | ﹤0.01% | 1487 |
|
|
2024
Q3 | – | Sell |
-25,858
| Closed | -$165K | – | 2119 |
|
|
2024
Q2 | $165K | Buy |
+25,858
| New | +$165K | ﹤0.01% | 1728 |
|
|
2024
Q1 | – | Sell |
-279,978
| Closed | -$2.59M | – | 2164 |
|
|
2023
Q4 | $2.59M | Sell |
279,978
-220,034
| -44% | -$2.04M | ﹤0.01% | 967 |
|
|
2023
Q3 | $5.06M | Buy |
500,012
+82,024
| +20% | +$830K | 0.01% | 779 |
|
|
2023
Q2 | $5.22M | Sell |
417,988
-633,978
| -60% | -$7.92M | 0.01% | 755 |
|
|
2023
Q1 | $12.3M | Sell |
1,051,966
-603,980
| -36% | -$7.05M | 0.03% | 555 |
|
|
2022
Q4 | $17.6M | Buy |
1,655,946
+516,367
| +45% | +$5.49M | 0.05% | 433 |
|
|
2022
Q3 | $11.1M | Buy |
1,139,579
+189,654
| +20% | +$1.84M | 0.03% | 522 |
|
|
2022
Q2 | $13.8M | Buy |
+949,925
| New | +$13.8M | 0.04% | 446 |
|
|
2022
Q1 | – | Sell |
-150,005
| Closed | -$5.94M | – | 2272 |
|
|
2021
Q4 | $5.94M | Buy |
+150,005
| New | +$5.94M | 0.02% | 670 |
|
|
2020
Q4 | – | Sell |
-11,982
| Closed | -$439K | – | 1300 |
|
|
2020
Q3 | $439K | Buy |
+11,982
| New | +$439K | ﹤0.01% | 902 |
|
|
2019
Q4 | – | Sell |
-20,611
| Closed | -$652K | – | 1162 |
|
|
2019
Q3 | $652K | Buy |
+20,611
| New | +$652K | ﹤0.01% | 786 |
|